Alkermes Balance Sheet
NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alkermes financial position
At the end of fiscal 2025, Alkermes reported total assets of $2.49 billion, up 21.0% from a year earlier against total liabilities of $667.7 million. Shareholders' equity stood at $1.82 billion, or 73.2% of assets. The company held $388.6 million in cash and equivalents against $0 of debt, a net cash position of $388.6 million.
The current ratio (current assets divided by current liabilities) was 3.55, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
Alkermes balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 388.57M | 291.15M | 457.47M | 292.47M | 337.54M | 272.96M | 203.77M | 266.76M | 191.30M | 186.38M |
| Short-Term Investments | 199.65M | 460.52M | 316.02M | 315.99M | 198.77M | 362.07M | 331.21M | 272.53M | 242.21M | 310.86M |
| Receivables | 334.02M | 384.53M | 332.48M | 287.97M | 313.19M | 275.14M | 257.09M | 292.22M | 233.59M | 191.10M |
| Inventory | 196.63M | 182.89M | 186.41M | 181.42M | 150.34M | 125.74M | 101.80M | 90.20M | 93.28M | 63.00M |
| Total Current Assets | 1.93B | 1.42B | 1.49B | 1.13B | 1.06B | 1.11B | 961.97M | 983.25M | 808.84M | 790.68M |
| Property, Plant & Equipment | 221.72M | 227.56M | 226.94M | 222.92M | 341.05M | 350.00M | 362.17M | 309.99M | 284.74M | 264.79M |
| Goodwill | 83.03M | 83.03M | 83.03M | 83.03M | 92.87M | 92.87M | 92.87M | 92.87M | 92.87M | 92.87M |
| Intangible Assets | 815.00K | 890.00K | 1.99M | 37.68M | 74.04M | 111.19M | 150.64M | 191.00M | 256.17M | 318.23M |
| Long-Term Investments | 145.00K | 73.15M | 39.89M | 131.61M | 229.43M | 24.78M | 79.39M | 80.74M | 157.21M | 121.93M |
| Total Assets | 2.49B | 2.06B | 2.14B | 1.96B | 2.02B | 1.95B | 1.81B | 1.83B | 1.80B | 1.73B |
| Accounts Payable | 107.95M | 45.63M | 65.65M | 32.84M | 55.72M | 46.03M | 54.26M | 39.77M | 55.53M | 46.27M |
| Short-Term Debt | 0 | — | 3.00M | 3.00M | 3.00M | 2.84M | 2.84M | 2.84M | 3.00M | 3.00M |
| Total Current Liabilities | 543.44M | 465.20M | 520.22M | 497.74M | 471.29M | 438.26M | 391.11M | 339.77M | 291.12M | 211.99M |
| Long-Term Debt | 0 | — | 287.73M | 290.27M | 292.80M | 272.12M | 274.30M | 276.46M | 278.44M | 280.67M |
| Total Liabilities | 667.70M | 590.59M | 933.54M | 920.23M | 911.90M | 882.75M | 719.96M | 653.72M | 594.42M | 516.94M |
| Shareholders' Equity | 1.82B | 1.46B | 1.20B | 1.04B | 1.11B | 1.07B | 1.09B | 1.17B | 1.20B | 1.21B |
| Retained Earnings | -734.79M | -976.46M | -1.34B | -1.70B | -1.54B | -1.49B | -1.38B | -1.19B | -1.04B | -947.94M |
| Total Debt | 0 | — | 290.73M | 293.27M | 295.80M | 274.96M | 277.14M | 279.31M | 281.44M | 283.67M |
| Net Cash (Debt) | 588.22M | 751.67M | 482.76M | 315.19M | 240.51M | 360.07M | 257.84M | 259.99M | 152.07M | 213.57M |
| Shares Outstanding | 165.61M | 162.18M | 166.98M | 164.38M | 161.94M | 159.16M | 157.78M | 155.76M | 154.01M | 152.43M |
This table shows 10 annual periods of Alkermes's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ALKS's reporting calendar. What is a balance sheet?